SAM KRUZEL

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 3-31-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses. H.R.5284 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act); to amend section 1862 of the Social Security Act with respect to the application of Medicare secondary payer rules to workers' compensation settlement agreements and Medicare set-asides under such agreements.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 6-30-2012; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to the preemption of state causes of action involving cosmetics. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.2156/S.3187 (Food and Drug Administration Safety and Innovation Act)/H.R.5651(Food and Drug Administration Reform Act); specific interest in preemption of state causes of action involving prescription drug manufacturers, medical device manufacturers and online pharmacies. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.5652 (Sequester Replacement Reconciliation Act); specific interest in provisions setting conditions for lawsuits arising from health care liabiltiy claims regarding health care goods or services or any medical product affecting interstate commerce. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce; lobbying on H.R. 5 generally; also specific interest in: H.AMDT.989, to address the crisis in access to emergency care by extending liability coverage to on-call and emergency room physicians under the Public Health Service Act; H.AMDT 990, to restore the application of antitrust laws to the business of health insurance by amending the McCarran-Ferguson Act; H.AMDT 991, to grant limited civil liability protection to health professionals that volunteer at federally declared disaster sites; and H.AMDT 988, to delay the date of enactment until the Secretary of Health and Human Services submits to Congress a report on the potential effect of this title on health care premiums. H.R.3511 (Cardiac Arrest Survival Act); to clarify liability protections regarding emergency use of automated external defibrillators. S.2264/H.R.4345 (Domestic Fuels Protection Act) to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives H.R. 4022 (Structured Settlement Claimaints Rights Act); to guarantee a claimant's right to retain a structured settlement broker to act on behalf of the claimant to negotiate a schedule of payments.

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses.

H.R. 1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 12-31-2011; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. (Fairness in Nursing Home Arbitration Act), draft legislation not formally introduced as of 12-31-2011; relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying on the issue of enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. Lobbying with regard to corporate accountability for exposure to asbestos and other toxic substances; and with regard to asbestos bankruptcy trusts.